660 related articles for article (PubMed ID: 18767411)
1. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases.
Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C
Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
3. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
[TBL] [Abstract][Full Text] [Related]
4. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
5. Cerebral manifestations in the antiphospholipid (Hughes) syndrome.
Sanna G; D'Cruz D; Cuadrado MJ
Rheum Dis Clin North Am; 2006 Aug; 32(3):465-90. PubMed ID: 16880079
[TBL] [Abstract][Full Text] [Related]
6. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
[TBL] [Abstract][Full Text] [Related]
7. The geoepidemiology of the antiphospholipid antibody syndrome.
Biggioggero M; Meroni PL
Autoimmun Rev; 2010 Mar; 9(5):A299-304. PubMed ID: 19932199
[TBL] [Abstract][Full Text] [Related]
8. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.
Lampropoulos CE; Koutroumanidis M; Reynolds PP; Manidakis I; Hughes GR; D'Cruz DP
Arthritis Rheum; 2005 Mar; 52(3):841-6. PubMed ID: 15751063
[TBL] [Abstract][Full Text] [Related]
9. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus.
Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J; Alarcón-Segovia D
J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
Avcin T; Silverman ED
Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
[TBL] [Abstract][Full Text] [Related]
11. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
[TBL] [Abstract][Full Text] [Related]
12. Ocular manifestations in antiphospholipid syndrome.
Suvajac G; Stojanovich L; Milenkovich S
Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
[TBL] [Abstract][Full Text] [Related]
13. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
[TBL] [Abstract][Full Text] [Related]
14. Peripheral vascular disease in antiphospholipid syndrome.
Vlachoyiannopoulos PG; Samarkos M
Thromb Res; 2004; 114(5-6):509-19. PubMed ID: 15507285
[TBL] [Abstract][Full Text] [Related]
15. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome.
Krause I; Lev S; Fraser A; Blank M; Lorber M; Stojanovich L; Rovensky J; Chapman J; Shoenfeld Y
Ann Rheum Dis; 2005 Oct; 64(10):1490-3. PubMed ID: 15778242
[TBL] [Abstract][Full Text] [Related]
16. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
17. [Neurological aspects in antiphospholipid syndrome].
Kitagawa Y
Rinsho Shinkeigaku; 2003 Nov; 43(11):744-7. PubMed ID: 15152454
[TBL] [Abstract][Full Text] [Related]
18. [Ischemic stroke at the young age: the role of antiphospholipid antibodies].
Kalashnikov LA
Angiol Sosud Khir; 2004; 10(4):8-12. PubMed ID: 15627129
[TBL] [Abstract][Full Text] [Related]
19. Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome).
Cimaz R; Meroni PL; Shoenfeld Y
Lupus; 2006; 15(4):191-7. PubMed ID: 16686257
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
Cervera R; García-Carrasco M; Font J; Ramos M; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ingelmo M
Clin Exp Rheumatol; 1997; 15(4):361-5. PubMed ID: 9272295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]